205 related articles for article (PubMed ID: 35490452)
1. Cytokine response over the course of COVID-19 infection in pregnant women.
Rosen DB; Murphy EA; Gejman RS; Capili A; Friedlander RL; Rand S; Cagino KA; Glynn SM; Matthews KC; Kubiak JM; Yee J; Prabhu M; Riley LE; Yang YJ
Cytokine; 2022 Jun; 154():155894. PubMed ID: 35490452
[TBL] [Abstract][Full Text] [Related]
2. Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile.
Rubio R; Aguilar R; Bustamante M; Muñoz E; Vázquez-Santiago M; Santano R; Vidal M; Melero NR; Parras D; Serra P; Santamaria P; Carolis C; Izquierdo L; Gómez-Roig MD; Dobaño C; Moncunill G; Mazarico E
Front Immunol; 2022; 13():999136. PubMed ID: 36238312
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the inflammatory response to COVID-19 illness in pregnancy.
Forrest AD; Poliektov NE; Easley KA; Michopoulos V; Ravi M; Cheedarla N; Neish AS; Cheedarla S; Roback JD; Dunlop AL; Badell ML; Dude CM
Cytokine; 2023 Oct; 170():156319. PubMed ID: 37544133
[TBL] [Abstract][Full Text] [Related]
4. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.
Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC
Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280
[TBL] [Abstract][Full Text] [Related]
5. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
[TBL] [Abstract][Full Text] [Related]
6. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.
Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255
[TBL] [Abstract][Full Text] [Related]
7. Panoramic snapshot of serum soluble mediator interplay in pregnant women with convalescent COVID-19: an exploratory study.
Fernandes GM; Sasaki LMP; Jardim-Santos GP; Schulte HL; Motta F; da Silva ÂP; de Carvalho AO; Pereira YR; Alves CO; de Araújo Júnior DA; Mendonça-Silva DL; Costa KN; de Castro MEC; Lauand L; Nery RR; Tristão R; Kurizky PS; Nóbrega OT; Espindola LS; de Castro LCG; Alpoim PN; Godoi LC; Dusse LMSA; Coelho-Dos-Reis JGA; do Amaral LR; Gomes MS; Bertarini PLL; Brito-de-Sousa JP; da Costa-Rocha IA; Campi-Azevedo AC; Peruhype-Magalhães V; Teixeira-Carvalho A; Zaconeta AM; Soares AASM; Valim V; Gomes CM; de Albuquerque CP; Martins-Filho OA; da Mota LMH
Front Immunol; 2023; 14():1176898. PubMed ID: 37122732
[TBL] [Abstract][Full Text] [Related]
8. Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2: a prospective multicenter cohort study.
Massalha M; Yefet E; Rozenberg O; Soltsman S; Hasanein J; Smolkin T; Alter A; Perlitz Y; Nachum Z
Clin Microbiol Infect; 2022 Sep; 28(9):1258-1262. PubMed ID: 35427778
[TBL] [Abstract][Full Text] [Related]
9. The rate of SARS-CoV-2 among asymptomatic non-immunised low-risk parturient women between the two waves.
Al-Hussaini TK; EzzEldin AM; Shaaban OM; Abdel-Aleem MA; Kamal DT; Ibrahim MN
J Obstet Gynaecol; 2022 Aug; 42(6):1868-1873. PubMed ID: 35484953
[TBL] [Abstract][Full Text] [Related]
10. CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome.
Guasp M; Muñoz-Sánchez G; Martínez-Hernández E; Santana D; Carbayo Á; Naranjo L; Bolós U; Framil M; Saiz A; Balasa M; Ruiz-García R; Sánchez-Valle R;
Front Immunol; 2022; 13():866153. PubMed ID: 35479062
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of the pro-inflammatory cytokine signature in severe COVID-19.
Hawerkamp HC; Dyer AH; Patil ND; McElheron M; O'Dowd N; O'Doherty L; Mhaonaigh AU; George AM; O'Halloran AM; Reddy C; Kenny RA; Little MA; Martin-Loeches I; Bergin C; Kennelly SP; Donnelly SC; Bourke NM; Long A; Sui J; Doherty DG; Conlon N; Cheallaigh CN; Fallon PG
Front Immunol; 2023; 14():1170012. PubMed ID: 37063871
[TBL] [Abstract][Full Text] [Related]
12. Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients.
Guo Y; Li T; Xia X; Su B; Li H; Feng Y; Han J; Wang X; Jia L; Bao Z; Li J; Liu Y; Li L
Front Immunol; 2021; 12():723585. PubMed ID: 34489974
[TBL] [Abstract][Full Text] [Related]
13. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients.
Lu Q; Zhu Z; Tan C; Zhou H; Hu Y; Shen G; Zhu P; Yang G; Xie X
Int J Clin Pract; 2021 Sep; 75(9):e14462. PubMed ID: 34107113
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of maternal-infant dyad inflammatory cytokines in pregnancies affected by maternal SARS-CoV-2 infection in early and late gestation.
Taglauer ES; Dhole Y; Boateng J; Snyder-Cappione J; Parker SE; Clarke K; Juttukonda L; Devera J; Hunnewell J; Barnett E; Jia H; Yarrington C; Sabharwal V; Wachman EM
J Perinatol; 2022 Oct; 42(10):1319-1327. PubMed ID: 35449446
[TBL] [Abstract][Full Text] [Related]
15. Severe acute respiratory syndrome coronavirus 2 serology levels in pregnant women and their neonates.
Kubiak JM; Murphy EA; Yee J; Cagino KA; Friedlander RL; Glynn SM; Matthews KC; Jurkiewicz M; Sukhu AC; Zhao Z; Prabhu M; Riley LE; Yang YJ
Am J Obstet Gynecol; 2021 Jul; 225(1):73.e1-73.e7. PubMed ID: 33497654
[TBL] [Abstract][Full Text] [Related]
16. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
[TBL] [Abstract][Full Text] [Related]
17. Does Maternal SARS-CoV-2 Infection or SARS-CoV-2 Vaccination Trigger an Inflammatory Response in the Fetus? A Prospective Cohort Study.
Alhousseini A; Turkoglu O; Sajja S; Wharton K; Idler J; Bahado-Singh R
Gynecol Obstet Invest; 2022; 87(3-4):219-225. PubMed ID: 35728583
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.
Sharma KA; Singh N; Hillman S; Mathur P; Yadav K; Garg A; Dadhwal V; Bhatla N
Int J Gynaecol Obstet; 2023 Jan; 160(1):74-78. PubMed ID: 35324007
[TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal microbiota profiling of pregnant women with SARS-CoV-2 infection.
Crovetto F; Selma-Royo M; Crispi F; Carbonetto B; Pascal R; Larroya M; Casas I; Tortajada M; Escudero N; Muñoz-Almagro C; Gomez-Roig MD; González-Torres P; Collado MC; Gratacos E
Sci Rep; 2022 Aug; 12(1):13404. PubMed ID: 35927569
[TBL] [Abstract][Full Text] [Related]
20. The impact of COVID-19 infection on the cytokine profile of pregnant women: A prospective case-control study.
Tanacan A; Yazihan N; Erol SA; Anuk AT; Yucel Yetiskin FD; Biriken D; Ozgu-Erdinc AS; Keskin HL; Moraloglu Tekin O; Sahin D
Cytokine; 2021 Apr; 140():155431. PubMed ID: 33503581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
